Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 mutations: A case report.
Saved in:
| Title: | Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 mutations: A case report. |
|---|---|
| Authors: | Zhong, Rui1 (AUTHOR), Li, Hui1 (AUTHOR), Liu, Yanling2 (AUTHOR), Zhang, Shuang3 (AUTHOR), Liu, Jingjing3 (AUTHOR), Huang, Zhicheng4 (AUTHOR), Cheng, Ying1,3 (AUTHOR) chengying@csco.org.cn |
| Source: | Thoracic Cancer. Feb2020, Vol. 11 Issue 2, p456-460. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 141526891 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 mutations: A case report. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Zhong%2C+Rui%22">Zhong, Rui</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Hui%22">Li, Hui</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Yanling%22">Liu, Yanling</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Shuang%22">Zhang, Shuang</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Jingjing%22">Liu, Jingjing</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Huang%2C+Zhicheng%22">Huang, Zhicheng</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cheng%2C+Ying%22">Cheng, Ying</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<i> chengying@csco.org.cn</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Thoracic+Cancer%22">Thoracic Cancer</searchLink>. Feb2020, Vol. 11 Issue 2, p456-460. 5p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=141526891 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/1759-7714.13286 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 5 StartPage: 456 Titles: – TitleFull: Chemotherapy combined with bevacizumab for the treatment of advanced lung adenocarcinoma cancer harboring EGFR‐ANXA2, EGFR‐RAD51, ATR and BRCA2 mutations: A case report. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhong, Rui – PersonEntity: Name: NameFull: Li, Hui – PersonEntity: Name: NameFull: Liu, Yanling – PersonEntity: Name: NameFull: Zhang, Shuang – PersonEntity: Name: NameFull: Liu, Jingjing – PersonEntity: Name: NameFull: Huang, Zhicheng – PersonEntity: Name: NameFull: Cheng, Ying IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: Feb2020 Type: published Y: 2020 Identifiers: – Type: issn-print Value: 17597706 Numbering: – Type: volume Value: 11 – Type: issue Value: 2 Titles: – TitleFull: Thoracic Cancer Type: main |
| ResultId | 1 |